These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1282607)

  • 1. New aspects of the treatment of ischemic heath disease with calcium antagonists. Proceedings of the International Nisoldipine Symposium. Düsseldorf, Germany, March 27-29, 1992.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S1-81. PubMed ID: 1282607
    [No Abstract]   [Full Text] [Related]  

  • 2. Nisoldipine improves ventricular function in rats with ischemic heart failure.
    Capasso JM
    J Mol Cell Cardiol; 1995 Sep; 27(9):1841-9. PubMed ID: 8523445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nisoldipine CC: clinical experience in ischaemic heart disease.
    Melcher A; Dens J; Curry P; Hagel H
    Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow.
    Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R
    J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats].
    An RH; Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):151-6. PubMed ID: 2816416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nisoldipine--a new calcium channel blocker for hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):13-4. PubMed ID: 8592476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nisoldipine in comparison with long-term nitrates].
    Eber B; Schumacher M; Zweiker R; Pokan R; Klein W
    Acta Med Austriaca; 1992; 19(5):137-9. PubMed ID: 1298142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence that nisoldipine attenuates stunning in patients post infarction.
    Kloner RA; Przyklenk K
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):17-8. PubMed ID: 9140671
    [No Abstract]   [Full Text] [Related]  

  • 11. The Ischaemic Heart: Beta-Blockade or Calcium Channel Blockade? Proceedings of a satellite symposium at the XIVth Congress of the European Society of Cardiology. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Oct; 14 Suppl F():1-34. PubMed ID: 7903241
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of stunning by the calcium antagonist nisoldipine in patients with myocardial infarction and early percutaneous transluminal coronary angioplasty.
    Heusch G
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):19-20. PubMed ID: 9140672
    [No Abstract]   [Full Text] [Related]  

  • 14. DEFIANT-II: a study of nisoldipine CC after myocardial infarction. Doppler flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy investigators.
    Hall R
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():881. PubMed ID: 9126677
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration.
    Letizia C; Barillà F; Cerci S; De Ciocchis A; Coassin S; Mastroianni MA; D'Ambrosio C; Campa PP; Scavo D
    Acta Cardiol; 1996; 51(2):165-72. PubMed ID: 8742913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of calcium antagonists on exercise tests.
    Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effects of m-nisoldipine and nisoldipine on myocardial damage in working rabbit hearts after ischemia-reperfusion].
    Zhang HL; Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):49-53. PubMed ID: 2554666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists in the therapy of ischemic heart disease].
    Makolkin BI; Vakhliaev VD
    Klin Med (Mosk); 1994; 72(1):4-7. PubMed ID: 8196322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.